Portfolio company
Revealis Biotherapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Infinitopes
This biotechnology company develops precision therapeutic cancer vaccines and antigen discovery platforms for healthcare providers and patients with solid tumours.
Bactheravax
This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.
Alphina Therapeutics
This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.
Geneos Therapeutics
This company develops personalised DNA-based therapeutic cancer vaccines and immunotherapies for patients with advanced hepatocellular carcinoma and other solid tumours.
Mnemo Therapeutics
This biotechnology company develops cell therapies and an epigenetic antigen discovery platform to treat solid tumours and blood cancers for healthcare providers.
Hubro Therapeutics
This company develops neoantigen-targeted cancer vaccines for patients with gastrointestinal cancers to activate anti-cancer specific T-cell immune responses.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Mersana Therapeutics
This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.
